Prevention of Nonsteroidal Anti-inflammatory Drug—Induced Gastrointestinal Mucosal Injury
- 11 November 1996
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 156 (20) , 2321-2332
- https://doi.org/10.1001/archinte.1996.00440190069008
Abstract
Research from JAMA Internal Medicine — Prevention of Nonsteroidal Anti-inflammatory Drug—Induced Gastrointestinal Mucosal Injury — A Meta-analysis of Randomized Controlled Clinical TrialsThis publication has 31 references indexed in Scilit:
- PMS53 UTILISATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN QUEBEC, CANADA: IS THERE A CHANGE IN THE PATIENT RISK PROFILE AFTER THE WITHDRAWAL OF ROFECOXIB?Value in Health, 2010
- RANITIDINE IN THE TREATMENT OF GASTRIC AND DUODENAL ULCERS ASSOCIATED WITH NON-STEROIDAL ANTI INFLAMMATORY DRUGSRheumatology, 1993
- Epidemiology of NSAID-induced gastropathyClinical Rheumatology, 1991
- Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers.Gut, 1991
- Misoprostol Reduces Gastroduodenal Injury From One Week of Aspirin: An Endoscopic StudyGastroenterology, 1989
- PREVENTION OF NSAID-INDUCED GASTRIC ULCER WITH MISOPROSTOL: MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALThe Lancet, 1988
- Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenumGastroenterology, 1988
- Overview of gastroduodenal mucosal protectionThe American Journal of Medicine, 1988
- Protection by misoprostol against naproxen-induced gastric mucosal damageThe American Journal of Medicine, 1987
- A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjectsDigestive Diseases and Sciences, 1986